Abstract
The necessity of probe validation of widely used iron oxide particles in molecular magnetic resonance imaging (mMRI) has called for a growing demand for simple detection and quantification methods in vitro and ex vivo. A simple option to adapt these particles to standard methods of biological research such as microscopy and flow cytometry is the conjugation of fluorescent dyes. With the rapid developing optical imaging techniques such magnetoptical probes could not only be used for mMRI, but also for in vivo fluorescence imaging. Furthermore, the option of screening magnetoptical particles for their binding affinity to target cells has been employed to optimize particle designs or to screen libraries of particles with unknown binding properties for their binding affinity to target cells. Finally, the conjugation of fluorescence dyes via specifically cleavable linkers to MR detectable nanoparticles provides the option to image probe distribution by MRI and single or even multiple enzyme functions by fluorescence imaging.
Thus, fluorescent dyes do not only add functionality for improving probes for mMRI, but also increase potential information content by enabling multi-modal imaging methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bremer, C., Tung, C.H., Weissleder, R., 2001. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7, 743–748.
Bulte, J.W., Hoekstra, Y., Kamman, R.L., Magin, R.L., Webb, A.G., Briggs, R.W., Go, K.G., Hulstaert, C.E., Miltenyi, S., The, T.H., et al., 1992. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 25, 148–157.
Bulte, J.W., Kraitchman, D.L., 2004. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17, 484–499.
Gleich, B., Weizenecker, J., 2005. Tomographic imaging using the nonlinear response of magnetic particles. Nature 435, 1214–1217.
Josephson, L., Kircher, M.F., Mahmood, U., Tang, Y., Weissleder, R., 2002. Near-Infrared Fluorescent Nanoparticles as Combined MR/Optical Imaging Probes. Bioconjug Chem 13, 554–560.
Kircher, M.F., Mahmood, U., King, R.S., Weissleder, R., Josephson, L., 2003. A multi-modal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 63, 8122–8125.
Kircher, M.F., Weissleder, R., Josephson, L., 2004. A dual fluorochrome probe for imaging proteases. Bioconjug Chem 15, 242–248.
Kobayashi, H., Brechbiel, M.W., 2003. Dendrimer-based macromolecular MRI contrast agents: characteristics and application. Mol Imaging 2, 1–10.
Moore, A., Medarova, Z., Potthast, A., Dai, G., 2004. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 64, 1821–1827.
Schellenberger, E.A., Reynolds, F., Weissleder, R., Josephson, L., 2004a. Surfacefunctionalized nanoparticle library yields probes for apoptotic cells. Chem Biochem 5, 275–279.
Schellenberger, E.A., Sosnovik, D., Weissleder, R., Josephson, L., 2004b. Magneto/optical annexin V, a multimodal protein. Bioconjug Chem 15, 1062–1067.
Schellenberger, E.A., Weissleder, R., Josephson, L., 2004c. Optimal modification of annexin V with fluorescent dyes. Chem Biochem 5, 271–274.
Sosnovik, D.E., Schellenberger, E.A., Nahrendorf, M., Novikov, M.S., Matsui, T., Dai, G., Reynolds, F., Grazette, L., Rosenzweig, A., Weissleder, R., Josephson, L., 2005. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 54, 718–724.
Taupitz, M., Schnorr, J., Abramjuk, C., Wagner, S., Pilgrimm, H., Hunigen, H., Hamm, B., 2000. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits. J Magn Reson Imaging 12, 905–911.
Tung, C.H., Bredow, S., Mahmood, U., Weissleder, R., 1999. Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjug Chem 10, 892–896.
Weissleder, R., Kelly, K., Sun, E.Y., Shtatland, T., Josephson, L., 2005. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 23, 1418–1423.
Weissleder, R., Lee, A.S., Khaw, B.A., Shen, T., Brady, T.J., 1992. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology. 182, 381–385.
Weissleder, R., Mahmood, U., 2001. Molecular imaging. Radiology 219, 316–333.
Weissleder, R., Tung, C.H., Mahmood, U., Bogdanov, A., Jr., 1999. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17, 375–378.
Wiener, E.C., Brechbiel, M.W., Brothers, H., Magin, R.L., Gansow, O.A., Tomalia, D.A., Lauterbur, P.C., 1994. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med 31, 1–8.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Schellenberger, E. (2008). Magnetoptical Probes. In: Bulte, J.W., Modo, M.M. (eds) Nanoparticles in Biomedical Imaging. Fundamental Biomedical Technologies, vol 102. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72027-2_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-72027-2_10
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72026-5
Online ISBN: 978-0-387-72027-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)